This is incredibly cheap at $120mio USD. So I'm estimating anything between USD$400mio to $1bio is feasible on good Nash Ph2results & ensuing partnership agreement with big pharma.
Share price at 400/600/800/1bio market caps:
USD$400mio being ~$84 per share on Nasdaq or $2.67 on the Australian ASX
Market cap of USD$600mio being $126 per Nasdaq share or $4 on the ASX
USD$800mio ~$168 on Nasdaq or $5.34 ASX
USD$1bio ~$210, $6.67 on ASX
Personally I think a share price of north of $126 on Nasdaq is easily achievable on positive PH2 NASH & pharma collaboration within a few months afterwards. This also completely ignores the very promising preclinical Cdiff pipeline, which has commenced a Phase 1/2 on 60 patients.
Also on a cash side, Immuron will have funds from warrants & options exercising, & also cash lump sum payment from big pharma collaboration.
Keen to hear your thoughts on the market cap projections. Good luck and let's hope for amazing PH2 Nash results & a fantastic partnering deal with a chunky lump sum.
Recent IMRN News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/09/2024 12:00:19 PM
- Immuron Plans Phase 2 Trial for IMM-529 following FDA review • GlobeNewswire Inc. • 09/05/2024 03:54:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 12:00:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/21/2024 01:28:04 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 12:00:02 PM
- Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan® • GlobeNewswire Inc. • 08/16/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 10:26:22 AM
- Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect • GlobeNewswire Inc. • 08/07/2024 10:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/22/2024 04:15:10 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/18/2024 10:14:35 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/15/2024 12:00:09 PM
- Immuron announces record Travelan® sales globally, Australia and USA • GlobeNewswire Inc. • 07/15/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/09/2024 10:09:39 AM
- Immuron requests pre-IND meeting for IMM-529 with FDA filing • GlobeNewswire Inc. • 07/02/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/05/2024 10:12:05 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/31/2024 12:00:38 PM
- Immuron Board Changes • GlobeNewswire Inc. • 05/31/2024 10:00:00 AM
- Immuron CEO Steven Lydeamore to present at Peak Sky High • GlobeNewswire Inc. • 05/31/2024 10:00:00 AM
- Immuron Director Resignation • GlobeNewswire Inc. • 05/03/2024 10:00:00 AM
- Immuron to host Live Virtual Event • GlobeNewswire Inc. • 04/15/2024 10:00:00 AM
- Immuron Travelan® sales continued strong growth • GlobeNewswire Inc. • 04/10/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 01:00:20 PM
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US • GlobeNewswire Inc. • 03/07/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/28/2024 01:08:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 01:00:38 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM